State Of Wyoming Gossamer Bio, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $32,620 - $54,476	-5,464 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $1,325 - $1,960	157 Added 2.96%	5,464 $47,000
Q4 2021 Feb 11, 2022	BUY	$10.12 - $14.07 $3,116 - $4,333	308 Added 6.16%	5,307 $60,000
Q3 2021 Feb 11, 2022	BUY	$7.25 - $13.23 $1,725 - $3,148	238 Added 5.0%	4,999 $63,000
Q2 2021 Feb 11, 2022	BUY	$8.0 - $9.75 $38,088 - $46,419	4,761 New	4,761 $39,000

114

190M

405K

490K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.